Child health Pregnancy Women's health
Breastfeeding problems
Last revised in June 2026
The World Health Organization (WHO) recommends exclusive breastfeeding until an infant is at least 6 months of age
Breastfeeding problems: Summary
- The World Health Organization (WHO) recommends exclusive breastfeeding until an infant is at least 6 months of age, with the introduction of solid food around this time and continued breastfeeding up to 2 years of age or longer.
- Benefits to the infant include a reduction in the incidence and severity of infections (including ear, chest, and gastrointestinal infections) and asthma.
- Benefits to the mother include reduced rates of breast and ovarian cancer, diabetes mellitus, and hypertensive heart disease.
- Breastfeeding problems which may lead to a mother stopping breastfeeding include:
- Breast pain.
- Nipple pain.
- Low milk supply (true and perceived).
- Oversupply of milk.
- Breastfeeding problems may have a number of underlying causes, and more than one problem may co-exist.
- Assessment should include history and examination of both the mother and infant, including observation of the woman breastfeeding and expressing milk by a person with appropriate training and expertise.
- Management should include:
- Advice on optimal infant positioning and attachment to the breast.
- Information on national and local breastfeeding support groups and organizations.
- Advice on continuing breastfeeding, wherever possible.
- Advice on simple analgesia and expression of milk, if appropriate.
- Advice on wearing a well-fitting bra and clothing that does not restrict the breasts.
- Treatment of any skin conditions or other underlying causes of symptoms, if present.
- Arranging a paediatric referral for the infant if there are concerns about dehydration, faltering growth, infant development, or the presence of an anatomical abnormality such as ankyloglossia (tongue-tie) that may be affecting infant attachment and feeding.
- Considering specialist referral for possible drug treatment if Raynaud's disease of the nipple, or prolactin deficiency causing a low milk supply, is suspected, and other measures have not worked.
- Considering referral to a breast specialist for further advice on management, if symptoms do not improve as expected with appropriate treatment.
Have I got the right topic?
From age 14 years onwards (Female).
This CKS topic covers the management of common problems with the breast, nipple, and milk supply that may occur during breastfeeding.
This CKS topic does not cover in detail the promotion and establishment of breastfeeding, or detail on the diagnosis and management of mastitis or breast abscess.
There are separate CKS topics on Breast cancer - recognition and referral, Breast pain - cyclical, Breast screening, and Mastitis and breast abscess.
The target audience for this CKS topic is healthcare professionals working within the NHS in the UK, and providing first contact or primary healthcare.
How up-to-date is this topic?
Changes
June 2026 — reviewed. A literature search was conducted in May 2026 to identify evidence-based guidelines, UK policy, systematic reviews, and key randomized controlled trials published since the last revision of the topic. No major changes to recommendations have been made.
Previous changes
February 2025 — minor update. Added detail to consider of blood testing for thyroid function and serum prolactin when low milk supply is suspected. Further minor changes to the information on ductal blockage, wording changed to compressed ducts following expert review.
August 2024 — minor update. Added information about the use of hydrocortisone cream in women who are breastfeeding. Added detail about the potential for over-diagnosis of candidal infection.
February 2022 — reviewed. A literature search was conducted in November 2021 to identify evidence-based guidelines, UK policy, systematic reviews, and key randomized controlled trials published since the last revision of the topic. Changes have been made to the section on management of suspected ductal infection to reflect a lack of evidence of the role of bacteria and yeast and to support the judicious use of antimicrobials.
May 2017 — minor update. Recommendations on use of soft paraffin or purified lanolin cream revised to reflect evidence-base.
December 2016 to January 2017 — reviewed. A literature search was conducted in November 2016 to identify evidence-based guidelines, UK policy, systematic reviews, and key randomized controlled trials published since the last revision of the topic. The topic has undergone significant restructuring. The section on prescribing information has been expanded. The scope of the topic has been reduced and the information on breast lumps and vitamin D supplementation has been removed, as this is covered in detail in the CKS topics on Breast cancer - recognition and referral and Vitamin D deficiency in adults - treatment and prevention. The lower age limit of the topic has been changed from 10 to 14 years.
May 2014 — minor update. The text has been updated to reflect advice from the UK Medicines Information Service and the European Medicines Agency regarding restrictions on prescribing domperidone.
January 2014 — minor update. Text updated in line with the Summary of Product Characteristics (SPCs) for miconazole oral gel to highlight the risk of choking in infants and young children when miconazole oral gel is applied to the mouth.
February 2013 — minor update. The 2013 QIPP options for local implementation have been added to this topic.
June 2012 — minor update. Typographical error corrected in background information section.
April 2012 — minor update. Information about the Department of Health's Healthy Start scheme and the importance for all breastfeeding women of taking a daily supplement containing 10 micrograms of vitamin D has been added.
February 2012 — minor update. McNeil Products Ltd, in collaboration with the Medicines and Healthcare products Regulatory Agency (MHRA), has published new safety data regarding the association of domperidone with an increased risk of serious ventricular arrhythmias or sudden cardiac death. This topic has been updated to reflect their advice on dosing, adverse effects, and drug interactions.
July 2011 — minor update. More exact paracetamol dosing for children has been introduced by the Medicines and Healthcare products Regulatory Agency (MHRA) following a press release (2011). Prescriptions have been updated to reflect the revised dosing.
June 2010 to February 2011 — this is a new CKS topic. The evidence-base has been reviewed in detail, and recommendations are clearly justified and transparently linked to the supporting evidence.
Update
New evidence
Evidence-based guidelines
No new evidence-based guidelines since 1 May 2026.
HTAs (Health Technology Assessments)
No new HTAs since 1 May 2026.
Economic appraisals
No new economic appraisals relevant to England since 1 May 2026.
Systematic reviews and meta-analyses
No new systematic reviews and meta-analyses since 1 May 2026.
Primary evidence
No new primary evidence which reaches the CKS threshold for inclusion published since 1 May 2026.
New policies
No new national policies or guidelines since 1 May 2026.
New safety alerts
No new safety alerts since 1 May 2026.
Changes in product availability
No changes in product availability since 1 May 2026.
Goals and outcome measures
Goals
To support primary healthcare professionals to:
- Help prevent breastfeeding problems.
- Recognize breastfeeding problems promptly.
- Assess the woman and infant, and refer to a breastfeeding specialist to assess and advise on positioning and attachment if needed.
- Manage breastfeeding problems in primary care, where appropriate.
- Refer to a specialist, when appropriate.
Outcome measures
No outcome measures were found during the review of this topic.Audit criteria
No audit criteria were found during the review of this topic.
QOF indicators
No QOF indicators were found during the review of this topic.QIPP - Options for local implementation
No QIPP indicators were found during the review of this topic.
NICE quality standards
Postnatal care
- Women receive breastfeeding support from a service that uses an evaluated, structured programme.
Background information
What are breastfeeding problems?
- The World Health Organization (WHO) recommends exclusive breastfeeding until an infant is 6 months of age, with the introduction of solid food around this time and continued breastfeeding up to 2 years of age or longer.
- Advantages for the infant include nutritional benefits, a reduction in the incidence and severity of infections (including ear, chest and gastrointestinal infections) and asthma. Studies have also shown that children and adolescents who were breastfed as babies are less likely to be overweight or obese.
- Advantages for the mother include reduced rates of breast and ovarian cancer, diabetes mellitus and hypertensive heart disease.
- Breastfeeding problems which may lead to a mother stopping breastfeeding include:
- Breast pain.
- Nipple pain.
- Low milk supply (true and perceived).
- Oversupply of milk.
- Effective and efficient breastfeeding requires optimal infant positioning and attachment to the breast. If this is not achieved, there may be:
- Reduced milk transfer.
- Reduced stimulation of breast milk production.
- Insufficient milk to match the infant's needs, leading to possible dehydration and faltering growth.
- Nipple pain and damage leading to other possible breastfeeding problems.
[Berens, 2016a; Westerfield, 2018; GPIFN, 2019a] [Pereira, 2021; Page, 2022; Douglas, 2022; ACOG, 2023; WHO, 2023; NICE, 2025a; NICE, 2025b; WHO, 2025]
What are the causes of breast pain?
There are a variety of causes of breast pain in breastfeeding women, and more than one cause may co-exist.
- Engorgement
- Primary engorgement occurs in the first few days after birth and is usually an indication that mature milk is being secreted. If milk is not removed effectively and frequently, the alveolar ducts distend, and the breasts become swollen and painful. As the body adjusts in response to the baby’s feeding, this congestion and swelling settles.
- Secondary engorgement can occur at various times throughout the breastfeeding period if there is an imbalance between milk production and removal, for example, if breastfeeding is less frequent or restricted (for example due to illness); infant demands decrease; or weaning off breastfeeding happens too quickly.
- Engorged breasts are painful, and oedema can prevent the baby from latching on well, increasing the risk of cracked nipples and more pain.
- Risk factors for severe symptomatic breast engorgement include large amounts of intravenous fluids during labour and past history of premenstrual breast tenderness or breast surgery.
- Compressed or blocked ducts
- These may be caused by milk stasis, due to ineffective removal of milk from part of the breast. This may be due to suboptimal positioning and attachment, infrequent breastfeeds, or the infant not being fed on demand. Other causes include tight clothing or trauma to the breast, which may obstruct milk flow.
- Compressed or blocked ducts may lead to the formation of a milk-filled cyst (galactocele) and/or mastitis.
- Ductal infection
- The phenomenon of 'ductal infection' is controversial in the literature, and definitions vary, with some overlap between bacterial dysbiosis, lactiferous ductal infection, and subacute mastitis.
- Proposed mechanisms include bacterial overgrowth and biofilm formation (possibly in conjunction with Candida), which may lead to narrowed lactiferous ducts and epithelial inflammation.
- Some studies have found a correlation between symptoms and the presence of Candida; others have not.
- Mastitis and breast abscess
- Mastitis may be infectious or non-infectious, and is usually secondary to milk stasis.
- A breast abscess is a localized collection of pus within the breast which requires urgent referral to secondary care for treatment.
- See the CKS topic on Mastitis and breast abscess for more information.
[Berens, 2016a; Westerfield, 2018; GPIFN, 2019b; GPIFN, 2019c; Zakarija-Grkovic, 2020] [Amir, 2021; Mitchell, 2022; ACOG, 2023; NICE, 2025b; WHO, 2025]
What are the causes of nipple pain?
There are a variety of causes of nipple pain in women who are breastfeeding, and more than one cause may co-exist.
- Physiological
- Nipple pain caused by initial milk let-down is common in the first few days post-partum, and usually settles within a few weeks when the infant removes milk effectively and frequently.
- Nipple damage
- Suboptimal infant positioning and attachment is the most common cause of nipple damage. Abnormal compression of the nipple between the tongue and hard palate may cause suction trauma.
- Infant anatomical conditions such as ankyloglossia (tongue-tie) may cause restricted tongue movement due to an abnormally short or thickened lingual frenulum, which may affect the infant's ability to suck. Cleft lip and/or palate may also cause nipple damage by affecting infant attachment to the breast.
- Maternal anatomical variation such as flat, inverted or large nipples (especially if non-protractile) may affect infant attachment. Nipple protractility usually improves in the first few weeks post-partum.
- Use of a breast pump with an ill-fitting flange or too high pressure may also cause breast or nipple trauma.
- Blocked ducts
- These may be caused by milk stasis, due to ineffective removal of milk from part of the breast.
- This may be due to suboptimal positioning and attachment, infrequent breastfeeds, or the infant not being fed on demand. Other causes include tight clothing or trauma to the breast, which may obstruct milk flow.
- Nipple infection
- Bacterial, fungal, or viral infection of the nipple/areola can occur.
- The association of Candida infection with nipple pain remains controversial, but if pain persists after effective positioning and attachment, Candida infection should be considered. There may be signs of associated infant oral or nappy area Candida infection, or infection may follow maternal or infant antibiotic treatment. See the CKS topics on Candida - skin and Candida - oral for more information.
- Bacterial infection may result from damaged skin over the nipple area being rapidly colonized with Staphylococcus aureus, which may be asymptomatic or may cause clinical infection. See the CKS topic on Impetigo for more information.
- Bacterial and candidal infection may co-exist.
- Viral infection of the nipple or breast can occur, for example, due to herpes simplex or varicella zoster. Be aware that transmission of some viral infections during breastfeeding can lead to serious illness, especially in neonates or immunocompromised children. For more information, see the CKS topics on Chickenpox and Herpes simplex.
- Skin conditions
- Atopic eczema on and around the areola may be triggered by skin irritants.
- See the CKS topic on Eczema - atopic for more information.
- Irritant contact dermatitis may be caused by breast pads, soaps, detergents, fragrances, and topical creams. Allergic contact dermatitis may be caused by skin care products, cosmetics, nail varnish, fragrances, and topical antibiotics.
- See the CKS topic on Dermatitis - contact for more information.
- Psoriasis may flare up post-natally, or as a response to skin injury (Koebnerization) from infant attachment, sucking, or biting.
- See the CKS topic on Psoriasis for more information.
- Paget's disease of the nipple (rare) may mimic eczema, but is usually unilateral, persistent, and unresponsive to treatments for eczema.
- See the CKS topic on Breast cancer - recognition and referral for more information.
- Be aware that any loss of epidermal integrity due to a skin condition may lead to secondary skin infection.
- Atopic eczema on and around the areola may be triggered by skin irritants.
- Nipple vasospasm or Raynaud's phenomenon of the nipple
- This is caused by episodic vasospasm and ischaemia of the small blood vessels of the nipples, often triggered by exposure to cold temperatures.
- It is more common in women with a known personal or family history of Raynaud's phenomenon of the digits, and it may be associated with underlying connective tissue disorders, such as rheumatoid arthritis or scleroderma.
- See the CKS topic on Raynaud's phenomenon for more information.
[Berens, 2016a; Westerfield, 2018; GPIFN, 2019c; Bourdillon, 2020; Johansson, 2020; Amir, 2021; Pereira, 2021; Douglas, 2022; ACOG, 2023; Evans, 2023; Moreira, 2024; BAD, 2025; WHO, 2025]
What are the causes of low milk supply?
There are a variety of causes of low milk supply in women who are breastfeeding, and more than one cause may co-exist.
- True maternal low milk supply is uncommon.
- If other causes have been excluded or are unlikely, there may be a subjective maternal perception of insufficient milk supply.
- Reduced milk intake by the infant.
- If the infant takes only small amounts of milk from the breast, milk production decreases, as effective milk removal is needed to stimulate milk supply. This may occur due to:
- Insufficient access to the breast (short or infrequent feeds, no night feeds, use of a dummy, nipple shield, giving supplementary feeds other than breast milk, maternal or infant illness, or regular mother-child separation, for example, due to work) — this results in reduced suckling at the breast and subsequently reduced milk production.
- Suboptimal removal of milk, for example, due to incorrect infant positioning and attachment.
- Maternal depression, stress, and/or anxiety, which may result in a reduced response to infant feeding cues and a reduced frequency of feeds and reduced stimulation of milk production.
- If the infant takes only small amounts of milk from the breast, milk production decreases, as effective milk removal is needed to stimulate milk supply. This may occur due to:
- Maternal prolactin deficiency related to:
- Drugs, such as oestrogen, combined hormonal contraceptives, dopamine, ergotamine, pyridoxine, nicotine, and alcohol.
- Anterior pituitary dysfunction, for example, due to severe post-partum haemorrhage and post-partum pituitary necrosis (Sheehan's syndrome, rare).
- Retained placental fragments.
- Thyroid disorders, for example, hypothyroidism or post-partum thyroiditis. Consider testing thyroid function to exclude thyroid disorders. See the CKS topics on Hypothyroidism and Hyperthyroidism for more information.
- Eating disorders such as bulimia.
- Maternal anatomical factors, such as:
- Hypoplastic breasts (rare, characterized by widely spaced breasts with prominent areolas, due to insufficient glandular tissue).
- Breast surgery (may interfere with normal nipple sensation which affects milk supply).
[Anderson, 2017; Brodribb, 2018; Grzeskowiak, 2019; GPIFN, 2019d; ACOG, 2023; SPS, 2024; WHO, 2025]
What are the causes of milk oversupply?
There are a variety of causes of milk oversupply in women who are breastfeeding, and more than one cause may co-exist:
- Physiological
- Milk oversupply is common in the first few weeks post-partum, as the mother adapts to the infant's requirements.
- Suboptimal infant positioning and attachment
- The infant may not remove milk efficiently and so suckles more, stimulating the breast to produce excessive milk.
- Breastfeeding pattern
- Moving the infant too early to the second breast before they have finished feeding from the first breast.
- Excessive expression of breast milk by hand or pump.
[Berens, 2016a; GPIFN, 2019b; Johnson, 2020; ACOG, 2023; WHO, 2025]
How common are breastfeeding problems?
- The UK has one of the lowest rates of breastfeeding in Europe — reasons for this are complex, but experience of problems while breastfeeding is likely to be a contributing factor [RCPCH, 2021].
- A review of national data from high-income countries found that the prevalence of any breastfeeding at 6 months varied from 4–78%. Rates were highest in Norway (78%), Finland (76%), Iceland (75%), and Sweden (63%). Lowest prevalence levels were reported by Wales (23%) and Northern Ireland (4%) [Vaz, 2021].
- Data on breastfeeding rates at 6 months in the UK is inconsistent, lacks standardization, and is not routinely collected for England or Scotland.
- The Infant Feeding Survey 2024 (a national survey asking mothers in England about their experiences of feeding their infants) found that [OHID, 2024]:
- In mothers who stopped breastfeeding when their babies were between 2–5 months (n=1475):
- 45% stopped because their baby was not latching on or was rejecting the breast.
- 44% stopped because they did not have enough milk.
- 25% stopped because they had painful breasts or nipples.
- 20% stopped because their baby was always hungry.
- In all mothers who had ever fed their baby breast milk up to 7 months (4527 mothers), nearly 3 in 5 (56%) stated that they had experienced pain, with similar proportions experiencing:
- Sore nipples with no obvious damage (31%).
- Sore nipples that were damaged or cracked or bleeding (25%).
- Painful breasts (25%).
- Overall, around 7 in 10 mothers who had fed their baby breast milk at any stage up to 7 months had experienced breastfeeding problems:
- 42% reported breast engorgement; 25% reported difficulty with the baby taking the breast or not sucking effectively; 25% reported insufficient milk; 20% reported blocked milk ducts; 17% reported tongue tie; and 12% reported mastitis.
- First-time mothers (76%) were more likely to have experienced difficulties compared with mothers who already had children (70%).
- Mothers living in the least deprived areas (79%) were more likely to have experienced difficulties while breastfeeding than mothers living in the most deprived areas (66%).
- In mothers who stopped breastfeeding when their babies were between 2–5 months (n=1475):
Diagnosis of breastfeeding problems
How should I assess a woman with breastfeeding problems?
Assessment should include history and examination of both the mother and infant.
- Ask about:
- Breastfeeding history, including:
- Concerns the parents have about their baby's feeding.
- Pattern of breastfeeding (frequency, duration, night feeds, one or both breasts offered).
- Presence of breast or nipple sensitivity before pregnancy.
- Milk supply issues (engorgement and low or oversupply).
- Expressing of milk (frequency, hand or pump used).
- Other fluids or foods given (when started, quantity, and frequency).
- Use of nipple shields or breast shells.
- Maternal beliefs, concerns, and expectations about breastfeeding, including sources of support and barriers to breastfeeding.
- Previous breastfeeding experiences, problems, and pain.
- Breast and/or nipple pain history, including:
- Time of onset post-partum.
- Presence of nipple trauma (abrasions, fissures, or bleeding).
- Timing (for example, with attachment, during breastfeeds, between breastfeeds, or with expressing of milk) and whether intermittent or constant.
- Location (for example, unilateral or bilateral, nipple and/or breast, superficial or deep).
- Character and severity (for example, burning, itching, sharp, or dull).
- Presence of associated signs and symptoms (such as fever, breast skin changes, malaise, nipple colour changes, nipple shape, or appearance after feeds).
- Exacerbating or relieving factors (such as cold, heat, massage, or touch).
- Previous treatments (such as analgesia and topical or oral drugs, including antibiotics).
- Maternal history, including:
- Complications during pregnancy, labour, or post-partum.
- Known medical conditions, such as thyroid disorders, diabetes, Raynaud's phenomenon, eczema or psoriasis, recent Candida or bacterial infection, chronic pain syndromes, and family history of ankyloglossia (tongue-tie).
- Previous breast surgery.
- Medications and allergies.
- Alcohol and smoking.
- Associated insomnia, stress, anxiety, or depression. For more information see CKS topics on Depression - antenatal and postnatal and Insomnia.
- Infant history, including:
- Birth gestation, birth trauma, and known medical conditions or congenital abnormalities.
- Birth weight, weight gain, general health, and behaviour (for example, settled or crying).
- Number of wet and dirty nappies (including stool colour).
- Behaviour at the breast (for example, rhythmic sucking and audible swallowing, pulling, biting, coughing, breathlessness, or sleepiness).
- Gastrointestinal symptoms which may suggest oversupply of milk, gastro-oesophageal reflux disease, or cows' milk protein allergy. For more information, see the CKS topics on GORD in children and Cows' milk protein allergy in children.
- Known ankyloglossia or cleft lip and/or palate and any treatment received.
- Use of a dummy or pacifier.
- Breastfeeding history, including:
- Examine the mother:
- Carry out a general examination, look for signs of infection or systemic illness.
- Inspect the nipples and breasts to identify flat or inverted nipples, skin damage, discharge, crusting, fissuring, discolouration, peau d’orange, individual lesions, or rashes.
- Palpate the breasts to identify any breast lumps, firmness, or tenderness.
- Examine the infant:
- Carry out a general examination, look for signs of dehydration, jaundice, lethargy, and inconsolability.
- Check head and neck symmetry, facial features and oral anatomy (ankyloglossia, palate, jaw, and lips), muscle tone, neurological maturity, and behaviour.
- Look for signs of oral Candida infection.
- Consider use of the UNICEF UK Baby Friendly Initiative Breastfeeding assessment form which may indicate when there is a breastfeeding problem requiring further assessment and observation of a full breastfeed.
- Ensure that a person with appropriate training and expertise (such as a health visitor or breastfeeding specialist) observes the woman:
- Breastfeeding to check:
- Maternal and infant positioning.
- Attachment (mouth wide-open with lips everted).
- Behaviour at the breast.
- Pattern of sucking.
- Shape and colour of nipples after feeding.
- Expressing milk to check:
- Hand and/or breast pump expressing technique.
- Breast shield/breast pump flange fit — nipple or breast trauma may occur due to breast pump use (for example from improper flange fit, excessive high pressure suction, or prolonged duration of use).
- Breastfeeding to check:
- Consider arranging a skin swab of the nipple and/or breast for microscopy and culture, if there is:
- Suspected bacterial, viral, or candida infection, particularly in the presence of vesicles of the nipple (this may indicate the presence of herpes simplex virus).
- Be aware that transmission of infections such as herpes simplex or varicella zoster to an infant can cause serious illness, especially in neonates or those with immunocompromise. If suspected, seek urgent specialist advice.
- See the section on nipple infection in Management for more information.
- An uncertain diagnosis — discuss with a specialist if unsure. In some cases, culture of breast milk may be indicated. For information on taking a sample for breast milk culture, see the CKS topic on Mastitis and breast abscess.
- Suspected bacterial, viral, or candida infection, particularly in the presence of vesicles of the nipple (this may indicate the presence of herpes simplex virus).
Basis for recommendation
The recommendations on how to assess a woman and infant when there are breastfeeding problems are largely based on clinical guidance from the US Academy of Breastfeeding Medicine (ABM) Persistent pain with breastfeeding [Berens, 2016a], the American College of Obstetricians and Gynecologists (ACOG) Breast feeding challenges: American College of Obstetricians and Gynecologists Committee Opinion Number 820 [ACOG, 2023] and the National Institute for Health and Care Excellence (NICE) Maternal and child nutrition: nutrition and weight management in pregnancy, and nutrition in children up to 5 years [NICE, 2025a] and Postnatal Care (NG194) [NICE, 2025b], the World Health Organization (WHO) publication Infant and young child feeding. Model chapter for textbooks for medical students and allied health professionals [WHO, 2025]; publications from the GP Infant Feeding Network UK Engorgement and Oversupply [GPIFN, 2019b] and Pain when Breastfeeding [GPIFN, 2019c] and expert opinion in review articles [Amir, 2021; Pereira, 2021; Page, 2022; Evans, 2023].
Discuss barriers to breastfeeding
- The Royal College of Paediatrics and Child Health position statement on breastfeeding in the UK states that societal attitudes may cause women to feel uncomfortable about breastfeeding in public or in the presence of peers and family members [RCPCH, 2021]. The NICE guideline committee emphasise the importance of reassuring women and their partners that under the 2010 Equality Act, women have the right to breastfeed in 'any public space' [NICE, 2025b].
Investigations
- The recommendations on potential investigations in primary care are based on clinical guidance from the US Academy of Breastfeeding Medicine (ABM) Persistent pain with breastfeeding [Berens, 2016a], expert opinion in a review article [Amir, 2021] and advice from an expert reviewer of this CKS topic.
How should I diagnose the cause of breast pain?
Following a full assessment of the woman and infant, diagnose the underlying cause of breast pain, where possible.
- Engorgement
- Breast pain typically starts in the first few days after birth, is often bilateral and worse before a feed.
- Infant attachment may be difficult due to breast fullness and milk flow may be reduced.
- The whole breast is typically swollen and oedematous and may be shiny, diffusely erythematous and may leak excessively.
- The nipple may be stretched and look flat in appearance.
- The infant may cough and pull off the breast on feeding or clamp down on the nipple during feeding to control flow.
- Compressed or blocked ducts
- May present with a localized, tender cord of tissue in one breast (usually a few centimetres in diameter), which may be relieved by expression of milk — overlying skin may be erythematous.
- A small white spot (bleb) about 1 mm in diameter may be present at the end of the nipple.
- Galactocele
- A galactocele develops when milk collects in a cyst-like cavity as a result of obstruction to flow due to a blocked or narrowed duct. It typically presents as a smooth, round, painless breast swelling which causes milky nipple discharge when pressed.
- Galactoceles may increase or fluctuate in size over time. They are not associated with erythema or systemic symptoms unless they become infected.
- Mastitis and breast abscess
- The woman often has a fever and is systemically unwell — mastitis may present with a hard painful swelling in a wedge-shaped distribution in one breast, with erythema of the overlying skin.
- A breast abscess may present with a worsening painful breast lump, which may be fluctuant, and the overlying skin is often erythematous and warm. There may be a persistent fever and systemic symptoms.
- See the CKS topic on Mastitis and breast abscess for more information.
- Neuropathic pain
- For more information please see the CKS topic on Neuropathic pain - drug treatment.
Basis for recommendation
The recommendations on how to diagnose the cause of breast pain are based on guidance from the GP Infant Feeding Network UK Engorgement and oversupply [GPIFN, 2019b] and Pain when Breastfeeding [GPIFN, 2019c], the American College of Obstetricians and Gynecologists: Breastfeeding challenges Committee Opinion Number 820 [ACOG, 2023], and the US Academy of Breastfeeding Medicine clinical protocols Persistent pain with breastfeeding [Berens, 2016a] and Engorgement [Mitchell, 2022], the World Health Organization (WHO) publication Infant and young child feeding - model chapter for textbooks [WHO, 2025], and review articles on breastfeeding problems [Gresh, 2019; Amir, 2021].
How should I diagnose the cause of nipple pain?
Following a full assessment of the woman and infant, diagnose the underlying cause of nipple pain, where possible.
- Physiological milk let-down pain
- There is often pain for the first few minutes of breastfeeding, which resolves with continuation of the feed.
- Pain often improves during the first few weeks of breastfeeding.
- Nipple damage
- Suboptimal positioning and attachment typically cause nipple pain at the start of a breastfeed that continues throughout the feed.
- Pressure from suckling may cause blanching and compression of the nipple, and fissuring across the top of the nipple or around the base. There may be flattening of the nipple from side to side, with a pressure line across the tip.
- Nipple damage may also occur due to infant ankyloglossia (tongue tie) or breast pump misuse or trauma.
- Compressed or blocked ducts
- Compressed or blocked ducts may be associated with a small white, yellow, or clear spot (bleb) about 1 mm in diameter (or larger) at the end of the nipple (sometimes called a milk bleb or blister). There may be a localized, tender cord of tissue in one breast, which may be relieved by expression of milk; the overlying skin may be erythematous.
- Nipple infection
- Bacterial infection may present with purulent nipple discharge, crusting, redness, and fissuring, and is often associated with skin trauma such as persistent cracks and fissures. See the CKS topic on Impetigo for more information.
- Viral infection (such as herpes simplex, herpes zoster or varicella zoster) may present with vesicular rash affecting the breast.
- Be aware that transmission of some viral infections during breastfeeding can lead to serious illness (which can be life-threatening), especially in neonates or immunocompromised children.
- For more information see the section on nipple infection in Management and the CKS topics on Chickenpox, Herpes simplex and Shingles.
- Candida infection — the association of Candida infection with nipple pain remains controversial, but if pain persists after effective positioning and attachment and other causes have been excluded, Candida infection should be considered.
- There may be signs of associated infant oral or nappy area Candida infection, or infection may follow maternal or infant antibiotic treatment.
- See the CKS topics on Candida - skin and Candida - oral for more information.
- Skin conditions
- Eczema, psoriasis, and contact dermatitis of the areola and nipple may cause itching of the skin.
- Eczema typically causes a bilateral red, dry, scaly rash which may have lichenified (thickened) areas, which tend to spare the base of the nipple.
- Psoriasis typically causes red plaques with clearly demarcated borders, which may have a fine overlying scale.
- Irritant dermatitis may occur due to soaps, nipple creams and other substances in direct contact with the breast.
- See the CKS topics on Eczema - atopic, Dermatitis - contact, and Psoriasis for more information.
- Paget's disease of the nipple may mimic eczema, but is usually unilateral, persistent, and unresponsive to treatment for eczema. In addition, there may be skin ulceration or erosions.
- See the CKS topic on Breast cancer - recognition and referral for more information.
- Eczema, psoriasis, and contact dermatitis of the areola and nipple may cause itching of the skin.
- Nipple vasospasm or Raynaud's phenomenon of the nipple
- Nipple pain (may be described as shooting, throbbing or burning) is typically intermittent, and present during and immediately after breastfeeds, and in between feeds if exposed to cold temperatures.
- Blanching of the nipple may be followed by cyanosis and/or erythema.
- Nipple pain resolves when the nipple returns to its normal colour.
- There may be a personal or family history of Raynaud's phenomenon of the digits. See the CKS topic on Raynaud's phenomenon for more information.
Basis for recommendation
The recommendations on how to diagnose the cause of nipple pain are based on guidance from GP Infant Feeding Network UK Engorgement and Oversupply [GPIFN, 2019b] and Pain when breast feeding [GPIFN, 2019c], the American College of Obstetricians and Gynecologists: Breastfeeding challenges: Committee Opinion Number 820 [ACOG, 2023], the US Academy of Breastfeeding Medicine clinical protocol Persistent pain with breastfeeding [Berens, 2016a], the World Health Organization (WHO) publication Infant and young child feeding - model chapter for textbooks [WHO, 2025], review articles [Westerfield, 2018; Amir, 2021; Pereira, 2021; Douglas, 2022; Evans, 2023; Moreira, 2024] and advice from an expert reviewer of this CKS topic.
How should I diagnose the cause of low milk supply?
Following a full assessment of the woman and infant, diagnose the underlying cause of low milk supply, where possible.
- Note that there may be a subjective maternal perception of insufficient milk supply. However, causes can include the following:
- Insufficient access to the breast
- Suggested by short or infrequent feeds, and/or no night feeds.
- Use of a dummy or giving supplementary feeds other than breast milk may also contribute.
- Maternal depression, stress, and/or anxiety may result in a reduced response to infant feeding cues and a reduced frequency of feeds, which leads to reduced stimulation of milk production.
- Suboptimal infant positioning and attachment
- Suggested by nipple pain/trauma; frequent feeding more than every 1 to 1.5 hours; no long intervals between feeds; feeding for less than five minutes or longer than 30 to 60 minutes duration.
- The infant may be generally unsettled, have faltering growth, or show signs of dehydration.
- Maternal prolactin deficiency
- Maternal conditions that may lead to prolactin deficiency and true low milk supply include thyroid disorders, polycystic ovarian syndrome, retained placenta, postpartum pituitary necrosis, alcohol use, and eating disorders.
- Some medications, such as hormonal contraception, can also have a suppressive effect on lactation.
- Consider testing thyroid function and serum prolactin levels, depending on the clinical presentation.
- See the CKS topics on Alcohol - problem drinking, Eating disorders, Hypothyroidism, Hyperthyroidism, and Polycystic ovarian syndrome, for more information.
- Maternal anatomical conditions such as hypoplastic breasts causing a lack of glandular tissue, or a history of breast surgery.
Basis for recommendation
The recommendations on how to diagnose the cause of perceived or true low milk supply are based on the World Health Organization (WHO) publication Infant and young child feeding. Model chapter for textbooks [WHO, 2025], guidance from the American College of Obstetricians and Gynecologists: Breastfeeding challenges [ACOG, 2023], the Academy of Breastfeeding Medicine Clinical Protocol #9: Use of Galactogogues in Initiating or Augmenting Maternal Milk Production [Brodribb, 2018], and the GP Infant Feeding Network Low Milk Supply [GPIFN, 2019d], a Cochrane review Oral galactagogues (natural therapies or drugs) for increasing breast milk production in mothers of non‐hospitalised term infants [Foong, 2020] and a review article [Westerfield, 2018].
How should I diagnose the cause of milk oversupply?
Following a full assessment of the woman and infant, diagnose the underlying causes of milk oversupply, where possible.
- Suboptimal infant positioning and attachment
- The infant may not remove milk efficiently so suckles a lot, stimulating the breast to produce excessive milk.
- Breastfeeding pattern
- Moving the infant too early to the second breast before they have finished feeding from the first breast.
- Overstimulation due to excessive expression (by hand or pump) between breastfeeds.
- The mother may describe:
- Breast fullness and possible engorgement or blocked ducts.
- A painful, forceful milk let-down reflex.
- Milk leakage and/or milk spraying from the opposite breast when feeding.
- The infant may:
- Choke and splutter when let-down occurs.
- Clamp down on the nipple or pull off the breast during feeds.
- Have colic or frequent explosive loose stools.
- Faltering growth if unable to feed adequately.
Basis for recommendation
The recommendations on the diagnosis of milk oversupply are based on expert opinion in the World Health Organization (WHO) publication Infant and young child feeding - model chapter for textbooks [WHO, 2025], the US Academy of Breastfeeding Medicine clinical protocol Persistent pain with breastfeeding [Berens, 2016a], and guidance from the GP Infant Feeding Network UK Engorgement and Oversupply [GPIFN, 2019b] and the American College of Obstetricians and Gynecologists: Breastfeeding challenges [ACOG, 2023].
Management
Scenario: Breastfeeding problems - management
From age 14 years onwards (Female).
What is the initial management for all women with breastfeeding problems?
For all women with breastfeeding problems:
- Ensure that a person with appropriate training and expertise (such as a health visitor or breastfeeding specialist) observes the woman breastfeeding and expressing milk to check and give advice on:
- Optimal infant positioning and attachment to the breast.
- Hand and/or breast pump milk expressing technique; level of suction; and fit of the flange.
- Initial breast fullness and nipple discomfort in the first few days post-partum, which may be normal as the milk 'comes in' and should improve as maternal milk supply adjusts to the infant's needs.
- Responsive feeding.
- Offer information on local and national breastfeeding support groups and organisations, such as:
- The National Childbirth Trust, which runs a telephone helpline including breastfeeding support (0300 330 0700), and provides antenatal courses and written information on breastfeeding issues and infant feeding.
- The Breastfeeding Network, which runs the national breastfeeding helpline (0300 100 0212) and provides written information on breastfeeding issues.
- The Association of Breastfeeding Mothers, which is a partner in the national breastfeeding helpline (0300 100 0212) and provides written information on breastfeeding issues.
- The La Leche League GB, which runs a telephone helpline (0345 120 2918), provides online help, runs local meetings, and provides written information on breastfeeding issues.
- Offer written information on optimal infant positioning and attachment, such as:
- The NHS Best Start in Life breastfeeding guides, which include information on Latching on, Breastfeeding positions and Breastfeeding challenges (including mastitis, milk supply, and sore nipples).
- Following assessment and advice on optimal infant positioning and attachment to the breast, if there is suspected:
- Engorgement — see the section on Engorgement.
- Compressed or blocked ducts — see the section on Compressed or blocked ducts.
- Galactocele — see the section on Galactocele.
- Ductal infection — see the section on Ductal infection.
- Mastitis or breast abscess — see the section on Mastitis or breast abscess.
- Nipple damage — see the section on Nipple damage.
- Nipple infection — see the section on Nipple Infection.
- Skin conditions — see the section on Skin conditions.
- Nipple vasospasm or Raynaud's phenomenon of the nipple — see the section on Nipple vasospasm.
- Low milk supply — see the section on Low milk supply.
- Milk oversupply — see the section on Milk oversupply.
- If symptoms do not improve as expected with appropriate treatment, consider discussion with/referral to a breast specialist for further advice on management.
How should I manage engorgement?
Following assessment and advice on optimal infant positioning and attachment to the breast, if there is suspected engorgement, advise the woman on:
- Feeding the infant with no restrictions on the frequency or length of feeds.
- Self-management techniques such as simple analgesia (for example paracetamol) for pain relief, minimal expressing of milk to relieve full breasts (excessive expression of milk may induce oversupply). Hand expressing a little milk to soften the areola prior to feeding may help if the baby is struggling to latch on due to breast engorgement.
- The use of cold packs after feeding or expressing to relieve pain and oedema.
- Wearing a well-fitting bra and clothing that does not restrict the breasts.
How should I manage compressed or blocked ducts?
Following assessment and advice on optimal infant positioning and attachment to the breast, if there is suspected compressed or blocked ducts:
- Advise the woman to feed from the affected breast frequently, avoid tight clothing that restricts the breasts and wear a well-fitting bra. Warm compresses and gentle massage towards the nipple while the baby is feeding may help.
- Advise the woman on signs of mastitis, which can develop as a complication of blocked ducts, and when to seek medical advice — see the CKS topic on Mastitis and breast abscess for more information.
- For a persistent breast mass, consider the possibility of an alternative diagnosis, such as breast cancer, and the need for referral — for more information, see the CKS topic on Breast cancer - recognition and referral.
How should I manage a galactocele?
Following assessment and advice on optimal infant positioning and attachment to the breast, if there is a suspected galactocele:
- Advise the woman to continue breastfeeding.
- Discuss with a breast specialist investigations to confirm diagnosis and treatment options if needed — occasionally image-guided aspiration may be used to confirm diagnosis.
- If there are any clinical features of concern or uncertainty about the diagnosis, see the CKS topic on Breast cancer - recognition and referral for more information on referral pathways.
How should I manage ductal infection?
Following assessment and advice on optimal infant positioning and attachment to the breast, if there is suspected ductal infection:
- Ensure that other causes of persistent breast/nipple pain have been excluded.
- Seek specialist advice regarding the need for investigations (such as nipple and breast milk cultures) and antimicrobial treatment — depending on the specific clinical situation, oral antibiotic or oral antifungal treatment may be indicated.
- For information on prescribing oral antimicrobials in breastfeeding, see the CKS topic on Mastitis and breast abscess.
How should I manage mastitis or breast abscess?
Following assessment and advice on optimal infant positioning and attachment to the breast, if there is suspected mastitis or breast abscess, see the CKS topic on Mastitis and breast abscess for detailed information on management in breastfeeding women.
How should I manage nipple damage?
Following assessment and advice on optimal infant positioning and attachment to the breast, if there is suspected nipple damage:
- Suboptimal infant positioning and attachment is the most common cause of nipple damage — ensure the woman has been reviewed by a person with appropriate training and expertise (such as a health visitor or breastfeeding specialist) and given advice and support.
- Arrange paediatric referral if there is an infant anatomical abnormality such as ankyloglossia (tongue-tie), for consideration of division of the lingual frenulum.
- Advise on stopping the use of nipple shields or breast shells, if appropriate, as these may contribute to incorrect positioning and attachment.
- Advise on considering the application of expressed breast milk, if the nipple skin is cracked or fissured.
How should I manage nipple infection?
Following assessment and advice on optimal infant positioning and attachment to the breast, if there is suspected nipple infection:
- If cellulitis, impetigo or mastitis is suspected, see the CKS topics on Cellulitis – acute, Impetigo and Mastitis and breast abscess for information on management.
- If a viral infection such as herpes simplex or varicella zoster is suspected, discuss management urgently with a specialist – be aware that transmission to an infant can cause serious illness, especially in neonates or those with immunocompromise.
- Advise the woman that contact between the affected breast and the infant should be avoided — the infant should not be breastfed or fed any expressed milk from the affected breast/nipple until lesions are healed to prevent transmission of infection.
- For more information, see the CKS topics on Chickenpox and Herpes simplex - oral.
- If Candida infection is suspected — see the CKS topics on Candida - skin and Candida - oral for more information.
- The association of Candida infection with nipple pain remains controversial, but if pain persists after effective positioning and attachment and other causes have been excluded, Candida infection should be considered. There may be signs of associated infant oral or nappy area Candida infection, or infection may follow maternal or infant antibiotic treatment.
- For additional information on use of topical antimicrobials in breastfeeding, see the Prescribing section.
How should I manage skin conditions?
Following assessment and advice on optimal infant positioning and attachment to the breast, if there is a suspected skin condition such as:
- Eczema:
- Advise on avoiding possible triggers if appropriate, such as lanolin, beeswax, or chamomile in nipple creams, soap, shampoo, and fragrances.
- Advise on the use of regular emollients and application of a topical corticosteroid to the nipples immediately after a breastfeed, the potency depending on the severity of the eczema.
- Before breastfeeding, the topical corticosteroid should be removed from all areas of the breast (especially nipples and areola areas) with warm water and reapplied after feeding — this is to prevent the infant’s mouth coming into direct contact with the topical corticosteroid.
- When applied to the breast, the use of creams is preferred to ointments owing to ease of removal before breastfeeding — use the least potent preparations for the shortest duration where possible. Hydrocortisone (mild potency) and clobetasone (moderate potency) are preferred for application to the nipple and areola area – avoid application of high potency steroids to these areas.
- See the CKS topics on Corticosteroids - topical (skin), nose, and eyes, Eczema - atopic and Dermatitis - contact for more information on management.
- Psoriasis:
- Advise on the use of regular emollients and topical treatment to the nipples, immediately after a breastfeed.
- See the CKS topic on Psoriasis for more information on management.
- Paget's disease of the nipple:
- Arrange urgent referral to a breast specialist using a suspected cancer pathway.
- See the CKS topic on Breast cancer - recognition and referral for more information.
How should I manage nipple vasospasm or Raynaud's phenomenon?
Following assessment and advice on optimal infant positioning and attachment to the breast, if there is suspected nipple vasospasm or Raynaud's phenomenon of the nipple:
- Advise on avoiding exposure to the cold, wearing warm clothing, breastfeeding in a warm environment, and self-management techniques such as the use of heat packs or a warm shower following a breastfeed or when there is breast pain.
- Advise on avoiding caffeine and stopping smoking, which can cause vasoconstriction, if appropriate. See the CKS topic on Smoking cessation for more information.
- If symptoms persist, consider discussion with/referral to an appropriate specialist, for consideration of a trial of oral nifedipine (off-label indication).
How should I manage low milk supply?
Following assessment and advice on optimal infant positioning and attachment to the breast, if there is suspected low milk supply:
- Arrange a paediatric referral (with urgency depending on the clinical situation) for the infant if there are concerns about dehydration, faltering growth, or infant development.
- Manage any underlying cause in the infant or woman that may be contributing to a low milk supply.
- Ensure that an assessment by a skilled lactation specialist has taken place to provide information on optimal positioning and attachment, skin-to-skin contact, feeding frequency, effective breast drainage, and expressing breastmilk.
- If these measures do not improve a true low milk supply and maternal prolactin deficiency or pituitary dysfunction is a possible cause, discuss with/refer to an endocrinologist for further investigations/management.
How should I manage milk oversupply?
Following assessment and advice on optimal infant positioning and attachment to the breast, if there is suspected milk oversupply:
- Ensure that the woman is aware of early feeding cues that suggest an infant is hungry, so that breastfeeds are initiated at appropriate times.
- Advise that if the infant is unable to attach effectively to the breast due to breast fullness, it may be helpful to express a small amount of milk (for example by hand expression) until the flow slows down, and then try to attach the infant to the breast. If a forceful let-down reflex continues, advise the woman that leaning back to breastfeed may be helpful.
- Ensure the woman has been assessed by person with appropriate training and expertise (such as a health visitor or breastfeeding specialist) to ensure optimal positioning and attachment. Feeding from one breast for each feed may be advised to help reduce milk supply.
- Advise on avoiding milk expression by hand or breast pump between feeds, if possible, to reduce overstimulation of milk supply.
Basis for recommendation
The recommendations on management of breastfeeding problems are largely based on expert opinion in the World Health Organization (WHO) publication Infant and young child feeding - model chapter for textbooks [WHO, 2025], guidance from the National Institute for Health and Care Excellence (NICE) Division of ankyloglossia (tongue-tie) for breastfeeding [NICE, 2026] and Postnatal Care (NG194) [NICE, 2025b], guidance from the GP Infant Feeding Network UK Engorgement and Oversupply [GPIFN, 2019b], Galactagogues [GPIFN, 2019e] and Pain when breast feeding [GPIFN, 2019c], the US Academy of Breastfeeding Medicine clinical protocols Persistent pain with breastfeeding [Berens, 2016a] and The Mastitis spectrum [Mitchell, 2022], guidance from the American College of Obstetricians and Gynecologists Breast feeding challenges [ACOG, 2023] and expert opinion in review articles [Gresh, 2019; Johansson, 2020; Amir, 2021; Douglas, 2022; Evans, 2023].
Advice on infant positioning and attachment to the breast
- With adequate practical support most mothers should be able to achieve successful breastfeeding through effective attachment at the breast and feeding according to the infant's needs. Suboptimal infant positioning and attachment is the most common cause of nipple damage [GPIFN, 2019c; RCPCH, 2021; Amir, 2021; NICE, 2025b; WHO, 2025].
Suspected engorgement
- These recommendations are based on the WHO publication on infant feeding [WHO, 2025], the ABM clinical protocol on engorgement [Mitchell, 2022], guidance from the GP Infant Feeding Network [GPIFN, 2019b], the ACOG guideline on Breastfeeding challenges [ACOG, 2023], the NICE clinical guideline on Postnatal care [NICE, 2025b] and expert opinion in review articles [Gresh, 2019; Amir, 2021].
- A Cochrane systematic review of 21 randomized and quasi-randomized controlled trials (2,170 women) found that the application of chilled cabbage leaves, cold gel packs, herbal compresses and massage may provide some benefit to breastfeeding women with breast engorgement, but the studies were small, heterogenous, and at high risk of bias. It concluded that there was insufficient evidence to recommend any specific intervention [Zakarija-Grkovic, 2020].
Suspected ductal infection
- The recommendations on management of suspected ductal infection are based on the US Academy of Breastfeeding Medicine clinical protocol Persistent pain with breastfeeding [Berens, 2016a], expert opinion in review articles [Baeza, 2016; Jiménez, 2017; Douglas, 2021] and what CKS considers to be good practice.
- The phenomenon of 'ductal infection' is controversial in the literature. Definitions vary with some overlap between bacterial dysbiosis, lactiferous ductal infection, and subacute mastitis. The ABM protocol states that the roles of bacteria and yeast remain unclear, both Staphylococcus sp and Candida have been identified on nipples and in breast milk of women without symptoms. Proposed mechanisms leading to symptoms (such as dull, deep aching breast pain and sharp shooting pain during milk ejection and breastfeeding) include bacterial overgrowth with bacterial biofilm formation (possibly including Candida sp) which may result in epithelial inflammation and narrowing of lactiferous ducts [Berens, 2016a].
- Some studies have found a correlation between symptoms and the presence of Candida while others have not [Berens, 2016a].
- Given the lack of consensus in the literature, CKS recommends excluding other causes of persistent breast and nipple pain and seeking advice from microbiology on investigations and management to ensure judicious and appropriate use of antimicrobials [Berens, 2016a].
- Some authors suggest that candidal infection is over-diagnosed in breastfeeding women and that other causes of breast pain may be attributable [Douglas, 2021].
Suspected nipple damage
- The recommendation on arranging referral for possible division of ankyloglossia (tongue-tie) is based on the NICE interventional procedure guidance, which found limited evidence that this procedure can improve breastfeeding problems [NICE, 2026], expert opinion in clinical guidance [ACOG, 2023] and a review article on nipple pain [Douglas, 2022].
- The recommendation on considering the application of expressed breast milk to the nipple is based on a Cochrane systematic review of four heterogenous randomized or quasi-randomized controlled trials (n = 656) of women with nipple pain. The authors concluded that 'the results from these four trials of good methodological quality suggested that applying nothing or just expressed breast milk may be equally or more beneficial in the short-term experience of nipple pain than the application of an ointment such as lanolin.' [Dennis, 2014].
Suspected skin conditions
- The recommendation to treat eczema or psoriasis of the nipple with topical preparations applied immediately after a breastfeed is to provide maximum contact time before the next breastfeed is based on clinical guidance from the ABM [Berens, 2016a] and the ACOG [ACOG, 2023].
- The NHS Specialist Pharmacy Service [SPS, 2023] recommends that all topical corticosteroids, should be removed from all areas of the breast, especially nipples and areola areas, before breastfeeding with warm water and reapplied after feeding.
Suspected nipple vasospasm and Raynaud's phenomenon of the nipple
- These recommendations are based on an ABM clinical protocol [Berens, 2016a], guidance from the GP infant Feeding Network [GPIFN, 2019c] and the ACOG [ACOG, 2023] and expert opinion in review articles [Amir, 2021; Pereira, 2021; Douglas, 2022; Moreira, 2024].
- CKS recommends specialist referral before consideration of drug treatments for nipple vasospasm and Raynaud’s disease (such as nifedipine) as this is an off-label indication.
Suspected low milk supply
- The recommendation on ensuring effective infant positioning and attachment is based on the fact that this is needed for an adequate milk supply — advice and support from a skilled breastfeeding specialist may help to resolve problems of perceived low milk supply [GPIFN, 2019e; ACOG, 2023; WHO, 2025].
- The recommendation on specialist referral where maternal prolactin deficiency or pituitary dysfunction is a possibility is based on clinical guidance [Brodribb, 2018] and expert review of this topic.
Suspected milk oversupply
- These recommendations are based on the WHO publication on infant feeding [WHO, 2025], clinical guidance from the ABM [Berens, 2016a], the UK GP Infant Feeding Network [GPIFN, 2019b] and the ACOG [ACOG, 2023].
- The recommendation to offer one breast for each feed is based on the 'block feeding' strategy, which allows the other breast to rest, allowing the fullness to provide feedback to the breast to subsequently reduce milk supply [Berens, 2016a]. The GP Infant Feeding Network [GPIFN, 2019b] recommend that this should only be considered after a specialist breastfeeding assessment.
Considering referral to a breast specialist if refractory symptoms
- This recommendation is pragmatic based on what CKS considers to be good clinical practice.
Prescribing information
Important aspects of prescribing information relevant to primary healthcare are covered in this section specifically for the drugs recommended in this CKS topic. For further information on contraindications, cautions, drug interactions, and adverse effects, see the electronic Medicines Compendium (eMC) or the British National Formulary (BNF).
Paracetamol
- For prescribing information on paracetamol, see the CKS topic on Analgesia - mild-to-moderate pain.
Topical fusidic acid
Dose
- For treatment of localised non-bullous impetigo or localised secondary bacterial infection of eczema in an adult:
- Apply fusidic acid 2% to the skin up to 3 times a day for 5 days.
- Fusidic acid can be used during breast-feeding but breastfeeding from the affected nipple should be avoided during treatment.
- Prolonged use may result in overgrowth of non-susceptible organisms.
Contraindications and cautions
- Do not prescribe topical fusidic acid to people with Hypersensitivity to the active substance or to any of the excipients.
- Topical fusidic acid should not be used for longer than 10 days, as extended or recurrent use may increase the risk of developing bacterial antibiotic resistance and contact sensitization.
- Contact with the eyes and mucous membranes should be avoided, as it may cause local irritation.
- The manufacturer recommends that breastfeeding from the affected nipple should be avoided during treatment with fusidic acid.
Adverse effects
Adverse effects are uncommon and include:
- Local skin irritation, erythema, contact dermatitis, eczema, or pruritus. If skin sensitization or severe local irritation is suspected, treatment should be stopped, and an alternative preparation should be given.
- Hypersensitivity reactions and angio-oedema (rare).
Drug interactions
- No drug interactions have been identified for topical fucidic acid. The likelihood is minimal as the systemic absorption of topical fucidic acid is negligible.
Pregnancy and breastfeeding
- The manufacturer recommends that breastfeeding from the affected nipple should be avoided during treatment with fusidic acid.
- The drug and lactation database (Lactmed) notes that data on excretion of fusidic acid into breastmilk are quite old and not from a well-designed study, but levels in breastmilk after intravenous fusidic acid appear to be low.
Topical miconazole
Dose
- Topical miconazole treatment for proven nipple candidiasis is recommended in clinical guidance [Berens, 2016b; ACOG, 2023] and review articles [Amir, 2021; Marshall, 2021] but dosage and duration of treatment are not specified.
- The BNF states that for fungal skin infection in an adult, topical miconazole should be applied twice daily, continuing for 10 days after lesions have healed, but does not specifically refer to treatment of nipples during breastfeeding.
- Application sparingly after a breastfeed is advised.
- Seek specialist advice if unsure.
Contraindications and cautions
- Do not prescribe topical miconazole to people with hypersensitivity to the active substance or to any of the excipients.
- Contact with the eyes and mucous membranes should be avoided, as it may cause local irritation.
- Topical miconazole is minimally absorbed systemically, and it is not known whether miconazole is excreted in breast milk. The manufacturer advises caution when using topical miconazole during breastfeeding.
Adverse effects
- Adverse effects are uncommon. Occasionally, local skin irritation and hypersensitivity reactions including a mild burning sensation, erythema, itching, and contact dermatitis may occur.
Drug interactions
- Drug interactions are rare with topical miconazole, due to its limited systemic availability. However, topical miconazole may enhance the anticoagulant effect of drugs such as warfarin, so monitoring of the anticoagulant effect should be arranged.
Pregnancy and breastfeeding
- Topical miconazole is minimally absorbed systemically — it is not known whether miconazole is excreted in breast milk; therefore, the manufacturer advises caution with use during breastfeeding.
- The drug and lactation database (LactMed) states that as miconazole has poor absorption from the skin and poor oral bioavailability, it is unlikely to adversely affect the breastfed infant, including after topical application to the nipples. LactMed also notes that:
- Miconazole ointment appears to have no advantage over lanolin for treating sore nipples during breastfeeding, and a survey of members of the Academy of Breastfeeding Medicine found that topical miconazole is rarely prescribed to nursing mothers to treat thrush.
- Any excess cream or ointment should be removed from the nipples before nursing.
- Only water-miscible cream or gel products should be applied to the breast because ointments may expose the infant to high levels of mineral paraffins via licking.
Topical mupirocin
Dose
- For bacterial skin infections, particularly those caused by Gram-positive organisms (except pseudomonal infection), apply mupirocin 2% three times a day for up to 10 days.
- For localised non-bullous impetigo, apply mupirocin 2% three times a day for 5 to 7 days.
- Washing the area thoroughly before breastfeeding is advised if mupirocin is used on the nipple.
- Prolonged use may result in overgrowth of non-susceptible organisms.
Contraindications and cautions
- Do not prescribe topical mupirocin to people with hypersensitivity to the active substance(s) or to any of the excipients.
- Avoid contact with the eyes.
- Renal impairment — avoid using ointment in moderate to severe impairment if absorption of large quantities may occur (contains polyethylene glycol, which is excreted renally).
- Prolonged use may result in overgrowth of non-susceptible organisms.
Adverse effects
- Adverse effects include:
- Skin reactions including burning, Itching, erythema, stinging, and dryness localised to the area of application.
- Systemic allergic reactions including anaphylaxis, generalised rash, urticaria, and angioedema have been very rarely reported.
- Pseudomembranous colitis — this is less likely to occur with topically applied mupirocin than oral antibiotics but should be considered if diarrhoea develops during or after antibiotic use.
Drug interactions
- No drug interactions have been identified.
Pregnancy and breastfeeding
- The manufacturer states that there is no information on the excretion of mupirocin in breastmilk and advises washing the area thoroughly before breastfeeding if mupirocin is used on the nipple.
- The drug and lactation database (Lactmed) states that as less than 1% is absorbed after topical application, mupirocin is considered a low risk to the nursing infant.
- Ensure that the infant's skin does not come into direct contact with the areas of skin that have been treated.
- Only water-miscible cream or gel products should be applied to the breast because ointments may expose the infant to high levels of mineral paraffins via licking.
Supporting evidence
This CKS topic is largely based on expert opinion in the World Health Organization (WHO) publication Infant and young child feeding - model chapter for textbooks [WHO, 2025], guidance from the National Institute for Health and Care Excellence (NICE) Postnatal Care (NG194) [NICE, 2025b], guidance from the GP Infant Feeding Network UK Engorgement and Oversupply [GPIFN, 2019b], Galactagogues [GPIFN, 2019e] and Pain when breast feeding [GPIFN, 2019c], the US Academy of Breastfeeding Medicine clinical protocols Persistent pain with breastfeeding [Berens, 2016a] and The Mastitis spectrum [Mitchell, 2022], guidance from the American College of Obstetricians and Gynecologists Breast feeding challenges [ACOG, 2023] and expert opinion in review articles on breastfeeding problems. The rationale for the individual recommendations is discussed in the relevant basis for recommendation sections.
How this topic was developed
This section briefly describes the processes used in developing and updating this topic. Further details on the full process can be found in the About Us section and on the Clarity Informatics website.
Search strategy
Scope of search
A literature search was conducted for guidelines, systematic reviews and randomized controlled trials on primary care management of breastfeeding.
Search dates
November 2021 - May 2026
Key search terms
Various combinations of searches were carried out. The terms listed below are the core search terms that were used for Medline.
- Breast Feeding/ breast.tw, breastfeed$.tw, exp Nipples/, nipple$.tw
- exp lactational disorders/ exp galactogogues/
- breast cyst/, galactocele.tw, Raynaud disease/, raynaud.tw, Breast Implants/, Mammaplasty/, cytomegalovirus Infections/, exp Cytomegalovirus/
- Breast feed$ or breast-feed$).ti,ab.
- Breast N3 engorg$.ti,ab.
Sources of guidelines
- National Institute for Health and Care Excellence (NICE)
- Scottish Intercollegiate Guidelines Network (SIGN)
- Royal College of Physicians
- Royal College of General Practitioners
- Royal College of Nursing
- NICE Evidence
- World Health Organization
- Guidelines International Network
- TRIP database
- Agency for Healthcare Research and Quality
- National Health and Medical Research Council (Australia)
- Royal Australian College of General Practitioners
- British Columbia Medical Association
- Canadian Medical Association
- Alberta Medical Association
- Michigan Quality Improvement Consortium
- Singapore Ministry of Health
- National Resource for Infection Control
- RefHELP NHS Lothian Referral Guidelines
- Medline (with guideline filter)
- Driver and Vehicle Licensing Agency
- NHS Health at Work (occupational health practice)
Sources of systematic reviews and meta-analyses
- The Cochrane Library:
- Systematic reviews
- Protocols
- Database of Abstracts of Reviews of Effects
- Medline (with systematic review filter)
- EMBASE (with systematic review filter)
Sources of health technology assessments and economic appraisals
- NIHR Health Technology Assessment programme
- The Cochrane Library:
- NHS Economic Evaluations
- Health Technology Assessments
- Canadian Agency for Drugs and Technologies in Health
- International Network of Agencies for Health Technology Assessment
Sources of randomized controlled trials
- The Cochrane Library:
- Central Register of Controlled Trials
- Medline (with randomized controlled trial filter)
- EMBASE (with randomized controlled trial filter)
Sources of evidence based reviews and evidence summaries
Sources of national policy
- Department of Health
- Health Management Information Consortium (HMIC)
Patient experiences
Sources of medicines information
The following sources are used by CKS pharmacists and are not necessarily searched by CKS information specialists for all topics. Some of these resources are not freely available and require subscriptions to access content.
Stakeholder engagement
Our policy
The external review process is an essential part of CKS topic development. Consultation with a wide range of stakeholders provides quality assurance of the topic in terms of:
- Clinical accuracy.
- Consistency with other providers of clinical knowledge for primary care.
- Accuracy of implementation of national guidance (in particular NICE guidelines).
- Usability.
Principles of the consultation process
- The process is inclusive and any individual may participate.
- To participate, an individual must declare whether they have any competing interests or not. If they do not declare whether or not they have competing interests, their comments will not be considered.
- Comments received after the deadline will be considered, but they may not be acted upon before the clinical topic is issued onto the website.
- Comments are accepted in any format that is convenient to the reviewer, although an electronic format is encouraged.
- External reviewers are not paid for commenting on the draft topics.
- Discussion with an individual or an organization about the CKS response to their comments is only undertaken in exceptional circumstances (at the discretion of the Clinical Editor or Editorial Steering Group).
- All reviewers are thanked and offered a letter acknowledging their contribution for the purposes of appraisal/revalidation.
- All reviewers are invited to be acknowledged on the website. All reviewers are given the opportunity to feedback about the external review process, enabling improvements to be made where appropriate.
Stakeholders
- Key stakeholders identified by the CKS team are invited to comment on draft CKS topics. Individuals and organizations can also register an interest to feedback on a specific topic, or topics in a particular clinical area, through the Getting involved section of the Clarity Informatics website.
- Stakeholders identified from the following groups are invited to review draft topics:
- Experts in the topic area.
- Professional organizations and societies (for example, Royal Colleges).
- Patient organizations, Clarity has established close links with groups such as Age UK and the Alzheimer’s Society specifically for their input into new topic development, review of current topic content and advice on relevant areas of expert knowledge.
- Guideline development groups where the topic is an implementation of a guideline.
- The British National Formulary team.
- The editorial team that develop MeReC Publications.
- Reviewers are provided with clear instructions about what to review, what comments are particularly helpful, how to submit comments, and declaring interests.
Patient engagement
Clarity Informatics has enlisted the support and involvement of patients and lay persons at all stages in the process of creating the content which include:
- Topic selection
- Scoping of topic
- Selection of clinical scenarios
- First draft internal review
- Second draft internal review
- External review
- Final draft and pre-publication
Our lay and patient involvement includes membership on the editorial steering group, contacting expert patient groups, organizations and individuals.
Evidence exclusion criteria
Our policy
Scoping a literature search, and reviewing the evidence for CKS is a methodical and systematic process that is carried out by the lead clinical author for each topic. Relevant evidence is gathered in order that the clinical author can make fully informed decisions and recommendations. It is important to note that some evidence may be excluded for a variety of reasons. These reasons may be applied across all CKS topics or may be specific to a given topic.
Studies identified during literature searches are reviewed to identify the most appropriate information to author a CKS topic, ensuring any recommendations are based on the best evidence. We use the principles of the GRADE and PICOT approaches to assess the quality of published research. We use the principles of AGREE II to assess the quality of published guidelines.
Standard exclusions for scoping literature:
- Animal studies
- Original research is not written in English
Possible exclusions for reviewed literature:
- Sample size too small or study underpowered
- Bias evident or promotional literature
- Population not relevant
- Intervention/treatment not relevant
- Outcomes not relevant
- Outcomes have no clear evidence of clinical effectiveness
- Setting not relevant
- Not relevant to UK
- Incorrect study type
- Review article
- Duplicate reference
Organizational, behavioural and financial barriers
Our policy
The CKS literature searches take into consideration the following concepts, which are discussed at the initial scoping of the topic.
- Feasibility
- Studies are selected depending on whether the intervention under investigation is available in the NHS and can be practically and safely undertaken in primary care.
- Organizational and Financial Impact Analysis
- Studies are selected and evaluated on whether the intervention under investigations may have an impact on local clinical service provision or national impact on cost for the NHS. The principles of clinical budget impact analysis are adhered to, evaluated and recorded by the author. The following factors are considered when making this assessment and analysis.
- Eligible population
- Current interventions
- Likely uptake of new intervention or recommendation
- Cost of the current or new intervention mix
- Impact on other costs
- Condition-related costs
- In-direct costs and service impacts
- Time dependencies
- Cost-effectiveness or cost-benefit analysis studies are identified where available.
We also evaluate and include evidence from NICE accredited sources which provide economic evaluations of recommendations, such as NICE guidelines. When a recommended action may not be possible because of resource constraints, this is explicitly indicated to healthcare professionals by the wording of the CKS recommendation.
Declarations of interest
Our policy
Clarity Informatics requests that all those involved in the writing and reviewing of topics, and those involved in the external review process to declare any competing interests. Signed copies are securely held by Clarity Informatics and are available on request with the permission of the individual. A copy of the declaration of interest form which participants are asked to complete annually is also available on request. A brief outline of the declarations of interest policy is described here and full details of the policy is available on the Clarity Informatics website. Declarations of interests of the authors are not routinely published, however competing interests of all those involved in the topic update or development are listed below. Competing interests include:
- Personal financial interests
- Personal family interest
- Personal non-financial interest
- Non-personal financial gain or benefit
Although particular attention is given to interests that could result in financial gains or losses for the individual, competing interests may also arise from academic competition or for political, personal, religious, and reputational reasons. An individual is not obliged to seek out knowledge of work done for, or on behalf of, the healthcare industry within the departments for which they are responsible if they would not normally expect to be informed.
Who should declare competing interests?
Any individual (or organization) involved in developing, reviewing, or commenting on clinical content, particularly the recommendations should declare competing interests. This includes the authoring team members, expert advisers, external reviewers of draft topics, individuals providing feedback on published topics, and Editorial Steering Group members. Declarations of interest are completed annually for authoring team and editorial steering group members, and are completed at the start of the topic update and development process for external stakeholders.
Competing interests declared for this topic:
None.
References
- ACOG (2023) Breastfeeding challenges. American College of Obstetricians and Gynaecologists. https://www.acog.org [Free Full-text]
- Amir, L.H., Baeza, C. and Charlamb, J.R. and Jones, W. (2021) Identifying the cause of breast and nipple pain during lactation. BMJ 374(3), n1628. [Abstract]
- Anderson, P.O. (2017) Drugs that suppress lactation, part 2. Breastfeeding Medicine 12(4), 199-201. [Abstract]
- BAD (2025) Contact Dermatitis. British Association of Dermatologists. https://bad.org.uk [Free Full-text]
- Baeza, C. (2016) Chronic mastitis, mastalgia, and breast pain. A narrative review of definitions, bacteriological findings, and clinical management. Clinical Lactation 7(1). [Free Full-text]
- Berens, P., Eglash, A., Malloy, M. and Steube, A.M. (2016a) ABM clinical protocol #26: Persistent pain with breastfeeding. Breastfeeding Medicine 11(2), 46-53. [Abstract]
- Berens, P. and Brodribb, W. (2016b) ABM clinical protocol #20: Engorgement. Breastfeeding Medicine 11(4), 159-163. [Abstract]
- BNF (2026) British National Formulary. National Institute for Health and Care Excellence. https://bnf.nice.org.uk [Free Full-text]
- Bourdillon, K. and McCausland, T. and Jones, S (2020) Latch-related nipple pain in breastfeeding women: the impact on breastfeeding outcomes. British Journal of Midwifery 28(7), 406-414. [Free Full-text]
- Brodribb, W. (2018) Use of galactogogues in initiating or augmenting maternal milk production. ABM Protocol. [Free Full-text]
- Dennis, C.L., Jackson, K. and Watson, J. (2014) Interventions for treating painful nipples among breastfeeding women (Cochrane Review). Issue 12. John Wiley & Sons, Ltd. http://www.cochranelibrary.com [Free Full-text]
- Douglas, P (2021) Overdiagnosis and overtreatment of nipple and breast candidiasis: A review of the relationship between diagnoses of mammary candidiasis and Candida albicans in breastfeeding women. Women's health 17, 1-10. [Abstract]
- Douglas, P. (2022) Re-thinking lactation-related nipple pain and damage. Women's Health 18, 17455057221087865. [Abstract]
- EMC (2025) SPC for mupirocin ointment 2%. Electronic Medicines Compendium. Datapharm Communications Ltd. https://www.medicines.org.uk/emc [Free Full-text]
- EMC (2026a) SPC for Fucidin 20 mg/g Cream. Electronic Medicines Compendium. Datapharm Communications Ltd. https://www.medicines.org.uk/emc [Free Full-text]
- EMC (2026b) SPC for Daktarin 2% Cream. Electronic Medicines Compendium. Datapharm Communications Ltd. https://www.medicines.org.uk/emc [Free Full-text]
- Evans, L., Lawson, H., Oakeshott, P., et al. (2023) Tongue-tie and breastfeeding problems. British Journal of General Practice 73(732), 297-298. [Abstract]
- Foong, S.C., Tan, M.L., Foong, W.C., et al. (2020) Oral galactagogues (natural therapies or drugs) for increasing breast milk production in mothers of non‐hospitalised term infants. Cochrane Database of Systematic Reviews 5(5). [Abstract]
- GPIFN (2019a) Importance of breastfeeding. GP Infant Feeding Network (UK). https://gpifn.org.uk [Free Full-text]
- GPIFN (2019b) Engorgement and Oversupply. GP Infant Feeding Network (UK). https://gpifn.org.uk [Free Full-text]
- GPIFN (2019c) Pain when breastfeeding. GP Infant Feeding Network (UK). https://gpifn.org.uk [Free Full-text]
- GPIFN (2019d) Low milk supply. GP Infant Feeding Network (UK). https://gpifn.org.uk [Free Full-text]
- GPIFN (2019e) Galactagogues. GP Infant Feeding Network UK. https://gpifn.org.uk [Free Full-text]
- Gresh, A., Robinson, K. and Thornton, C. P. and Plesko, C. (2019) Caring for women experiencing breast engorgement: A case report. Journal of Midwifery & Women's Health 64(6), 763-768. [Abstract]
- Grzeskowiak, L.E. and Wlodek, M.E. and Geddes, D.T. (2019) What evidence do we have for pharmaceutical galactagogues in the treatment of lactation insufficiency? - A narrative review. Nutrients 11(5), 28. [Abstract]
- Jiménez, E., Arroyo, R., Cárdenas, N., et al. (2017) Mammary candidiasis: A medical condition without scientific evidence? PLoS One 12(7), e0181071. [Abstract]
- Johansson, M., Fenwick, J. and Thies-Lagergren, L. (2020) Mothers' experiences of pain during breastfeeding in the early postnatal period: A short report in a Swedish context. American Journal of Human Biology 32(3), e23363. [Abstract]
- Johnson, H.M., Eglash, A., Mitchell, K.B., et al. (2020) Academy of Breastfeeding Medicine (ABM) clinical protocol# 32: Management of hyperlactation. Breastfeeding Medicine 15(3), 129-134. [Abstract]
- LactMed (2022) Miconazole. Drugs and Lactation Database. [Free Full-text]
- LactMed (2024) Mupirocin. Drugs and Lactation Database. [Free Full-text]
- LactMed (2025) Fusidic Acid. Drugs and Lactation Database. [Free Full-text]
- Marshall, J., Ross, S., Buchanan, P. and Gavine, A. (2021) Providing effective evidence based support for breastfeeding women in primary care. BMJ 375, e065927. [Abstract]
- Mitchell, K.B., Johnson, H.M., Rodrı´guez, J.M., et al. (2022) Academy of Breastfeeding Medicine Clinical Protocol #36:The Mastitis Spectrum. Breastfeeding Medicine. https://www.bfmed.org [Free Full-text]
- Moreira, T.G., Castro, G.M. and Gonçalves Júnior, J. (2024) Raynaud's phenomenon of the nipple: epidemiological, clinical, pathophysiological, and therapeutic characterization. International Journal of Environmental Research and Public Health 21(7), 849. [Abstract]
- NICE (2022) Postnatal Care QS37. National Institute for Health and Care Excellence. https://www.nice.org.uk [Free Full-text]
- NICE (2025a) Maternal and child nutrition: nutrition and weight management in pregnancy, and nutrition in children up to 5 years. National Institute for Health and Care Excellence. https://www.nice.org.uk [Free Full-text]
- NICE (2025b) Postnatal Care. National Institute for Health and Care Excellence. https://www.nice.org.uk [Free Full-text]
- NICE (2026) Division of ankyloglossia (tongue-tie) for breastfeeding HealthTech guidance HTG95. National Institute for Health and Care Excellence. https://www.nice.org.uk [Free Full-text]
- OHID (2024) Infant feeding survey in England 2024. Office for Health Improvement and Disparities. https://www.gov.uk [Free Full-text]
- Page, A.E., Emmott, E, H. and Myers, S. (2022) Testing the buffering hypothesis: Breastfeeding problems, cessation, and social support in the UK. American Journal of Human Biology 34(2), e23621. [Abstract]
- Pereira, M. and Thable, A. (2021) Raynaud's phenomenon of the nipple: Ensuring timely diagnosis. Journal of the American Association of Nurse Practitioners 33(4), 271-277. [Abstract]
- RCPCH (2021) Breast feeding in the UK: position statement. Royal College of Paediatrics and Child Health. https://www.rcpch.ac.uk [Free Full-text]
- SPS (2023) Using inhaled or topical corticosteroids during breastfeeding. Specialist Pharmacy Service. https://www.sps.nhs.uk [Free Full-text]
- SPS (2024) Using benzodiazepines during breastfeeding. Specialist Pharmacy Service. https://www.sps.nhs.uk [Free Full-text]
- Vaz, J.S., Maia, M.F.S., Neves, P.A., et al. (2021) Monitoring breastfeeding indicators in high‐income countries: Levels, trends and challenges. Maternal & Child Nutrition 17(3), e13137. [Abstract]
- Westerfield, K.L., Koenig, K. and Oh, R. (2018) Breastfeeding: common questions and answers. American Family Physician 98(6), 368-376. [Abstract]
- WHO (2023) Infant and young child feeding: Factsheet. World Health Organization. https://www.who.int [Free Full-text]
- WHO (2025) Infant and young child feeding: model chapter for textbooks for medical students and allied health professionals, 2nd ed. World Health Organisation. https://www.who.int [Free Full-text]
- Zakarija-Grkovic, I. and Stewart, F. (2020) Treatments for breast engorgement during lactation. Issue 9(9). John Wiley & Sons, Ltd. http://www.cochranelibrary.com [Free Full-text]